[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @jeromeleonard5 jerome leonard jerome leonard posts on X about $idya, $ucb, $bmy, $tngx the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::2574682512/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +7.70% - X Months XXXXXX -XX% - X Year XXXXXXX +3,738% ### Mentions: X [#](/creator/twitter::2574682512/posts_active)  - X Week XX +47% - X Month XX +27% - X Months XX -XX% - X Year XXX +2,082% ### Followers: XXXXX [#](/creator/twitter::2574682512/followers)  - X Week XXXXX +0.13% - X Month XXXXX +0.76% - X Months XXXXX +5.60% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::2574682512/influencer_rank)  ### Social Influence [#](/creator/twitter::2574682512/influence) --- **Social category influence** [currencies](/list/currencies) XXXX% [stocks](/list/stocks) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% [travel destinations](/list/travel-destinations) XXXX% **Social topic influence** [$idya](/topic/$idya) 1.41%, [$ucb](/topic/$ucb) 1.41%, [$bmy](/topic/$bmy) 1.41%, [$tngx](/topic/$tngx) 1.41%, [$cere](/topic/$cere) 1.41%, [take the](/topic/take-the) 1.41%, [mount everest](/topic/mount-everest) 1.41%, [$gsk](/topic/$gsk) 1.41%, [$zlab](/topic/$zlab) XXXX% **Top accounts mentioned or mentioned by** [@bioinvestor24](/creator/undefined) [@avidresearch](/creator/undefined) [@notgenentech](/creator/undefined) [@jacobplieth](/creator/undefined) [@biovalues](/creator/undefined) [@dmitrykovalchuk](/creator/undefined) [@biotechport](/creator/undefined) [@17thfellow](/creator/undefined) [@nociftw](/creator/undefined) [@amylucio2009](/creator/undefined) [@bigpharmaguy](/creator/undefined) [@biotechobserver](/creator/undefined) [@pikacapital](/creator/undefined) [@notthatkindofdr](/creator/undefined) [@stl_biotech](/creator/undefined) [@sanctuarybio](/creator/undefined) [@profoak](/creator/undefined) [@quantumup1](/creator/undefined) [@bradloncar](/creator/undefined) [@drmakaryfda](/creator/undefined) **Top assets mentioned** [IDEAYA Biosciences, Inc. Common Stock (IDYA)](/topic/$idya) [United Community Banks, Inc. (UCB)](/topic/$ucb) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Cere Network (CERE)](/topic/$cere) [GSK plc (GSK)](/topic/$gsk) ### Top Social Posts [#](/creator/twitter::2574682512/posts) --- Top posts by engagements in the last XX hours "397+ trodelvy $idya" [X Link](https://x.com/jeromeleonard5/status/1965005568525181085) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-09-08T10:53Z 2267 followers, 6647 engagements "@nociFTW Could and should have done something big a long time ago to derisk the pipe. Still could but they most certainly wont in a bull market" [X Link](https://x.com/jeromeleonard5/status/1978509687336153160) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-15T17:14Z 2270 followers, XXX engagements "@BioValues @Amylucio2009 IF they're moving so fast through the doses with a t-cell engager it isn't a good sign. CRC only focus also isn't a good one" [X Link](https://x.com/jeromeleonard5/status/1978121105081549114) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-14T15:29Z 2267 followers, XXX engagements "$bmy prmt5 going after 1L mtap Pdac $tngx Study named: Moutain-TAP30 😆" [X Link](https://x.com/jeromeleonard5/status/1976152404081950943) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-09T05:07Z 2267 followers, 1744 engagements "At least $cere management was smart enough to take the $ when they could" [X Link](https://x.com/jeromeleonard5/status/1972371841584169019) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-09-28T18:44Z 2267 followers, 2314 engagements "@BigChodu XX% SI explains the ramp. 800m EV for a pre P2 onc company is frotty. High bar for differentiation for XXX vs bmy. As for the brain penetrant prmt5 gbm is Mount Everest but here no one made it past base camp. Funded for another X quarters so they need $ 25/30% dilution coming" [X Link](https://x.com/jeromeleonard5/status/1979073077171380239) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-17T06:32Z 2270 followers, XXX engagements "$gsk prmt5 bites the dust" [X Link](https://x.com/jeromeleonard5/status/1968285534989750769) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-09-17T12:06Z 2267 followers, 2192 engagements "@JacobPlieth @NotthatkindofDr Started dosing in jan/feb. Most likely asco 26" [X Link](https://x.com/jeromeleonard5/status/1977740168070156580) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-13T14:16Z 2267 followers, XXX engagements "@BioValues @Amylucio2009 You do get it that the rapid dose escalation and the narrowing of the indication to only crc are two opposites at this stage of development. Makes no sense at all" [X Link](https://x.com/jeromeleonard5/status/1978122341839245580) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-14T15:34Z 2267 followers, XXX engagements "ORR dropping from a cliff for 3rd line + patients should make it clear which one has the best eff. If we focus on the XXX dose $zlab is losing very deep resp pretty fast. For me the gr3 ae profile just look too good and this will come at cost of exposure levels & durability" [X Link](https://x.com/jeromeleonard5/status/1965424142859264078) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-09-09T14:36Z 2270 followers, 1284 engagements "@NotthatkindofDr @JacobPlieth Id wait for the gsk update before drawing any conclusions on wrn. Data will be better than roche" [X Link](https://x.com/jeromeleonard5/status/1977720701680242965) [@jeromeleonard5](/creator/x/jeromeleonard5) 2025-10-13T12:58Z 2267 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@jeromeleonard5 jerome leonard
jerome leonard posts on X about $idya, $ucb, $bmy, $tngx the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXXX +7.70%
- X Months XXXXXX -XX%
- X Year XXXXXXX +3,738%
Mentions: X #
- X Week XX +47%
- X Month XX +27%
- X Months XX -XX%
- X Year XXX +2,082%
Followers: XXXXX #
- X Week XXXXX +0.13%
- X Month XXXXX +0.76%
- X Months XXXXX +5.60%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence currencies XXXX% stocks XXXX% cryptocurrencies XXXX% travel destinations XXXX%
Social topic influence $idya 1.41%, $ucb 1.41%, $bmy 1.41%, $tngx 1.41%, $cere 1.41%, take the 1.41%, mount everest 1.41%, $gsk 1.41%, $zlab XXXX%
Top accounts mentioned or mentioned by @bioinvestor24 @avidresearch @notgenentech @jacobplieth @biovalues @dmitrykovalchuk @biotechport @17thfellow @nociftw @amylucio2009 @bigpharmaguy @biotechobserver @pikacapital @notthatkindofdr @stl_biotech @sanctuarybio @profoak @quantumup1 @bradloncar @drmakaryfda
Top assets mentioned IDEAYA Biosciences, Inc. Common Stock (IDYA) United Community Banks, Inc. (UCB) Bristol-Myers Squibb Co (BMY) Cere Network (CERE) GSK plc (GSK)
Top Social Posts #
Top posts by engagements in the last XX hours
"397+ trodelvy $idya"
X Link @jeromeleonard5 2025-09-08T10:53Z 2267 followers, 6647 engagements
"@nociFTW Could and should have done something big a long time ago to derisk the pipe. Still could but they most certainly wont in a bull market"
X Link @jeromeleonard5 2025-10-15T17:14Z 2270 followers, XXX engagements
"@BioValues @Amylucio2009 IF they're moving so fast through the doses with a t-cell engager it isn't a good sign. CRC only focus also isn't a good one"
X Link @jeromeleonard5 2025-10-14T15:29Z 2267 followers, XXX engagements
"$bmy prmt5 going after 1L mtap Pdac $tngx Study named: Moutain-TAP30 😆"
X Link @jeromeleonard5 2025-10-09T05:07Z 2267 followers, 1744 engagements
"At least $cere management was smart enough to take the $ when they could"
X Link @jeromeleonard5 2025-09-28T18:44Z 2267 followers, 2314 engagements
"@BigChodu XX% SI explains the ramp. 800m EV for a pre P2 onc company is frotty. High bar for differentiation for XXX vs bmy. As for the brain penetrant prmt5 gbm is Mount Everest but here no one made it past base camp. Funded for another X quarters so they need $ 25/30% dilution coming"
X Link @jeromeleonard5 2025-10-17T06:32Z 2270 followers, XXX engagements
"$gsk prmt5 bites the dust"
X Link @jeromeleonard5 2025-09-17T12:06Z 2267 followers, 2192 engagements
"@JacobPlieth @NotthatkindofDr Started dosing in jan/feb. Most likely asco 26"
X Link @jeromeleonard5 2025-10-13T14:16Z 2267 followers, XXX engagements
"@BioValues @Amylucio2009 You do get it that the rapid dose escalation and the narrowing of the indication to only crc are two opposites at this stage of development. Makes no sense at all"
X Link @jeromeleonard5 2025-10-14T15:34Z 2267 followers, XXX engagements
"ORR dropping from a cliff for 3rd line + patients should make it clear which one has the best eff. If we focus on the XXX dose $zlab is losing very deep resp pretty fast. For me the gr3 ae profile just look too good and this will come at cost of exposure levels & durability"
X Link @jeromeleonard5 2025-09-09T14:36Z 2270 followers, 1284 engagements
"@NotthatkindofDr @JacobPlieth Id wait for the gsk update before drawing any conclusions on wrn. Data will be better than roche"
X Link @jeromeleonard5 2025-10-13T12:58Z 2267 followers, XXX engagements